ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Thyroid Cancer Briefing Planned

July 8, 1977

Oncology Nursing Society Names 15 To Advisory Panel.

September 29, 2000

Environmental Emphasis Urged, Including New Role For Comp Centers NCAB Unenthusiastic

March 21, 1975

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989